Get rid of market barriers to appropriate pain management
Health insurers, pharmacy benefit management companies and others are making it harder for physicians to provide appropriate care to patients living with pain.
AMA passes opioid policies to end barriers to non-opioid treatment
The AMA approved several opioid-related policies intended to put the focus of pain treatment back on patients and away from arbitrary third-party controls.
New AMA president: Time for physicians to create history together
In ascending to one of medicine’s highest offices, new AMA president Patrice A. Harris, MD, MA, has completed an unlikely journey.
Patrice A. Harris, M.D., inaugurated as 174th president of the AMA
Patrice A. Harris, M.D., M.A., was sworn in today as the 174th president of the AMA. Dr. Harris is the first African-American woman to hold the office.
AMA strengthens its policies promoting naloxone access and education
Physicians and medical students acted today to strengthen existing AMA policy promoting increased access to naloxone, the opioid overdose-reversing drug.
Physicians take steps against opioid epidemic, mortality rises
AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.
Doctors make progress on opioids, call on policymakers to do more
Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment.
AMA Opioid Task Force recommendations offer roadmap to policymakers
The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.
AMA calls pain task force recommendations a road map for future policy
The AMA backs proposals the Interagency Pain Task Force discussed, a signal that policy makers understand the treatment required for patients in pain.